Mereo BioPharma Group plc (MREO)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
17
$6.05B held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| BANK OF AMERICA CORP /DE/ | Aug 14, 2026 | $2.60B |
| MILLENNIUM MANAGEMENT LLC | May 15, 2026 | $1.17B |
| BALYASNY ASSET MANAGEMENT L.P. | Feb 17, 2026 | $533.49M |
| UBS Group AG | Aug 13, 2026 | $460.35M |
| TWO SIGMA INVESTMENTS, LP | Aug 14, 2026 | $419.12M |
MREO's filings are public. The insight is one click away.
Scrutar's AI reads every MREO filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze MREO filingsNo credit cardAI reports included on the free plan
Never miss a MREO filing.
Get an email when MREO files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 30, 2026Source: SEC EDGAR.